Market Overview

Benzinga's M&A Chatter for Thursday April 28, 2016


The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday April 28, 2016:

Comcast's NBCUniversal to Acquire DreamWorks Animation for $41/Share Cash

The Deal:
NBCUniversal, a division of Comcast Corporation (NASDAQ: CMCSA) announced Thursday, the acquisition of DreamWorks Animation (NASDAQ: DWA) for approximately $3.8 billion or $41 per share in cash. The transaction is expected to close by the end of 2016, subject to antitrust approvals.

DreamWorks closed at $39.95 on Thursday, up 24.07%.

Abbott to Acquire St. Jude Medical for $46.75/in Cash, 0.8708 Shares

The Deal:
Abbott (NYSE: ABT) and St. Jude Medical, Inc. (NYSE: STJ) announced Thursday, an agreement, under which Abbott will acquire St. Jude for $46.75 in cash and 0.8708 shares of Abbott common stock. The total consideration is approximately $85 per share.

The transaction is expected to close in Q4 of 2016.

St. Jude Medical closed at $77.79 on Thursday, up 25.57%.

Sanofi Offers to Acquire Medivation for $52.50/Share in Cash

The Offer:
Sanofi (NYSE: SNY) announced Thursday, that it sent a letter to Medivation, Inc., (NASDAQ: MDVN), with a non-binding proposal to acquire Medivation for $52.50 per share in cash. The offer is not contingent on any financing condition.

Medivation confirmed it received the unsolicited, non-binding proposal from Sanofi and said it expects to complete its review of the proposal at a scheduled meeting on Thursday.

Medivation closed at $56.17 on Thursday, up 7.92%.

Qlik Technologies Said to have Received Preliminary Offers from Thoma Bravo, Bain Capital, Permira

The Rumor:
Qlik Technologies Inc. (NASDAQ: QLIK) is said to have received preliminary offers from private equity firms Thoma Bravo, Bain Capital and Permira, while Vista Capital Partners is considering an offer, according to sources as reported by Bloomberg on Thursday. The sources said Qlik is working with Morgan Stanley to find potential buyers.

Spokespersons for Qlik, Thoma Bravo, Bain and Permira declined comment on the report.

Qlik Technologies closed at $29.88 on Thursday, up 3.25%.

AbbVie Acquires Stemcentrx for ~$5.8B in Cash, Stock

The Deal:
AbbVie (NYSE: ABBV) announced Thursday, that it will acquire Stemcentrx for approximately $5.8 billion in cash and stock. Approximately $2.0 billion of the transaction value will be paid in cash, with the balance in stock. Stemcentrx investors are eligible to receive up to $4 billion in cash, based on milestone payments for the achievement of certain regulatory and clinical developments.

The transaction is expected to close in Q2 of 2016.

AbbVie closed at $61.20 on Thursday, up $0.50.

Posted-In: M&A News Movers


Related Articles (ABT + ABBV)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at